曼曼在海南
04-29
$同源康医药-B(02410)$
南向资金持续保持较高持股比例,且近期出现净增持,内资投资者对公司核心产品的商业化前景和管线价值具有较强信心,是公司股价的重要支撑力量
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":558780274133112,"tweetId":"558780274133112","gmtCreate":1777452747211,"gmtModify":1777452749358,"author":{"id":4184381897673700,"idStr":"4184381897673700","authorId":4184381897673700,"authorIdStr":"4184381897673700","name":"曼曼在海南","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 南向资金持续保持较高持股比例,且近期出现净增持,内资投资者对公司核心产品的商业化前景和管线价值具有较强信心,是公司股价的重要支撑力量</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 南向资金持续保持较高持股比例,且近期出现净增持,内资投资者对公司核心产品的商业化前景和管线价值具有较强信心,是公司股价的重要支撑力量</p></body></html>","text":"$同源康医药-B(02410)$ 南向资金持续保持较高持股比例,且近期出现净增持,内资投资者对公司核心产品的商业化前景和管线价值具有较强信心,是公司股价的重要支撑力量","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/558780274133112","repostId":0,"isVote":1,"tweetType":1,"viewCount":423,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":150,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/558780274133112"}
精彩评论